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Biological Markers During Early Pregnancy:
Trophoblastic Signals of the
Pern-mplantation Period
by Stanley R. Glasser,* JoAnne Julian,* M. Idrees Munir,*
and Michael J. Soares*t
The peri-implantation period extends from the time the blastocyst is free in the uterus, through the
processes of recognition and attachment, to the beginning of trophoblast differentiation and the inter-
actions between the embryo andthe uterine endometrium which initiate establishment ofthe hemochorial
placenta. It is duringthe peri-implantation period that the embryo and hormonally regulated endometrial
cells appear to be most sensitive to factors which introduce risk into the intrauterine environment.
There arenomarkerswhichcanbeusedpracticallytoassesspregnancyriskduringtheperi-implantation
period of either human or laboratory rodents. Experimental studies, using in vitro laboratory models of
differentiating trophoblast cells, have identified peptide hormone markers of pivotal developmental pro-
cesses. Exposureoftrophoblastduringtheexpression ofthese processescouldhave severeandfar-reaching
effects individually and societally. While these trophoblast signals are limited in their utility with respect
tohealthmonitoringextrapolation ofthesefindingstohumanpregnancy, thesignalscouldservetoidentify
more practical and sensitive markers to assess risk in early gestation.
Human chorionic gonadotropin (hCG) has been used extensively as a marker to assess risk during the
early stages of pregnancy. Extrapolation of experimental data indicates how hCG could be used more
effectively in analyses ofpossible cause and effect relationships. The limitations of hCG as a marker for
risk during the human peri-implantation period are discussed. Peptide hormones which could serve to
assess risk during this critical period ofextraordinary sensitivity to toxic factors are introduced.
Introduction
It is during the immediate peri-implantation period
whenthe maternaluterine environment andthe embryo
are interacting to establish pregnancy that the uterus
and embryo appear to be the most sensitive and sus-
ceptible to factors which bring the greatest risk to bear
on the successful and uneventful completion of gesta-
tion. Thedatawhichsupportthisperemptorystatement
have accumulated over the last two centuries. The
chances of a couple of proven fertility to conceive off-
spring in any one menstrual cycle is about 25% (1,2). It
remains more difficult to categorize to what extent this
high failure rate is due to errors or dysfunctions in ovu-
lation, fertilization, implantation, or subsequent devel-
opment. In animal husbandry there is a high incidence
ofearly embryonic loss, as great as 40% in pigs. It has
beenestimated that as many as 50% ofpresumed human
conceptions may similarly be due to early embryonic
losses (2,3).
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To an extent, the records of human in vitro fertiliz-
ation/embryo transfer (IVF/ET) programs validate
these estimates. The success rates, 15 to 20%, are mar-
ginally below the accepted norm. However, these rates
are disconcerting when it is appreciated that the fer-
tilized embryos that are transferred represent a se-
lected population. The deficit is attributable to the fail-
ure of events that are related to implantation (4,5).
Since errors in implantation appear to be one of the
largest, if not the single largest, cause offailure in ap-
parently reproductively competent individuals (Fig. 1),
it is rational to suggest that this extraordinary sensi-
tivity to risk could be compounded further by the in-
troduction ofxenobiotic agents intothe intrauterine en-
vironment.
Laboratory Models
In the United States, solution ofthis problem cannot
be aided by prospective experimentation. This option
is effectively foreclosed by ethical constraints and legal
restrictions (6,7). For this reason the study of early
development inthehumanhasnecessarilybecome more
dependent on knowledge derived from comparative
studies than have other areas of human biology. Ma-GLASSER ET AL.
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FIGURE 1. The relative contribution of different stages of very
early gestation to the outcome of an early in vitro fertilization/
embryo transfer program. This figure summarizes data that re-
ported results in a treatment group that resulted in the first suc-
cessful IVF/ET pregnancy (4). Ofthe 79 women monitored during
the course ofspontaneous menstrual cycles, 68 women underwent
laparoscopy for attempted oocyte retrieval resulting in the deliv-
ery at term of two normal infants (5).
terial available for study is represented by examples of
almost all the divergent evolutionary trials ofthe mam-
malian reproductive systems; as such, they are imper-
fect analogies ofhuman reproduction. Nevertheless, di-
vergence often being a better teacher than simulation,
comparative analysis has provided the insight that has
allowed common mechanisms characteristic ofthe pre-
implantation period to be identified (8).
Itisimportant toappreciate thatanimalexperiments,
particularly invitrolaboratorymodels, areonlymodels.
The usefulness of these analogies is correlated to the
extentthemodelmimics the specific process beingstud-
ied and is thus a function of our understanding. The
caveats inherent in the design and execution of labo-
ratory models (9) limit, but do not discount, the oppor-
tunity to focus on a distinct target or unique toxin-
specific cellular or molecular event that alters the re-
productive or developmental outcome. The accuracy
with which such events can be identified and the pre-
cision with which they can be analyzed is constitutive
to the experimental model only to the degree that we
understand the process under investigation and its pu-
tative role in the program ofdifferentiation.
Xenobiotics and the
Peri-Implantation Period
Givenalmost anydefinition ofbiomarkers itis evident
that there are no truly specific or reliable markers for
xenobioticagentsthatcanyetbeexactlycorrelatedwith
any ofthe cellular and molecular events ofearly mam-
maliandevelopment. Itistruethatthere aredatawhich
permit the generalization that events of early devel-
opment are adversely influenced by a variety of toxic
agents (10). However, the data derive fromstudies that
were not stringently designed or executed and often
wereanalyzedretrospectively. Theirusefulness iniden-
tifying specific sensitive loci is gratuitous. The possi-
bility ofovercomingsuch deficiencies is inhibited bythe
paucity ofvalid, stage-specific markers ofreproductive
anddevelopmental eventsperse. Thefewputativeearly
event markers thatmight prove useful (cleavage rates,
compaction, blastocoelation, expression of embryonic
mRNA, expressionandorganizationoftrophectodermal
cytokeratins, etc.) have rarely, if ever, been used in
studies ofreproductive toxicology.
The identification ofxenobiotics that produce human
reproductive anddevelopmentalaberrationsdepends on
the integrative analysis of at least three types of mon-
itoring, i.e., environmental, biological, and health. The
concept of a biological marker as a signal for a repro-
ductive ordevelopmental eventthatcanbeusedto mon-
itor the effect ofa xenobiotic agent is well established.
However, there are no markers of this sort, markers
that are medically and economically effective and can
satisfy the pragmatics of normal human life, available
for the analysis of those events related to the peri-im-
plantation period inhuman orothermammalianspecies.
Thus, there remains a compelling need to identify valid
and effective markers. The usefulness of such putative
markers will be determined, interms ofanyxenobiotic,
by their ability to identify specific and/or sensitive tar-
gets, bytherole ofthesetargets innormalbiology(e.g.,
willthe preferential localization and accumulation ofthe
xenobiotic by a specific cell be ofany consequence), and
by the nature and/or degree of the effect (i.e., death,
anomaly, dysfunctions, quality ofsurvival) (Fig. 16).
Implantation
Implantation of the mammalian embryo within the
uterus of the maternal host is a unique interaction be-
tween two genetically dissimilar organisms. For most
species, close coordination ofchanges in the developing
embryo and the uterus, probably initiated while the
embryo is still in the oviduct, is required. Disruption of
this synchrony leads to failure ofthe implantation pro-
cess. Synchrony (11) is the concept that defines the
highlyregulated integration ofmultistepdevelopmental
programs, proceeding independently in the intercom-
municating epithelial and stromal cells of the uterine
endometrium and in the embryo, that is obligatory for
the blastocyst to interact with the sensitized uterine-
epithelium at a species-specific time.
The idea that in response to changing ratios of pro-
gesterone and estrogen, the uterus matures from ahos-
tile to a neutral, nonreceptive to a receptive environ-
ment for the blastocyst and that implantation is a
property ofthe receptive uterus, is supported by phys-
iological data (12-14) and confirmed by morphological
(15,16), and to a lesser extent, by biochemical, corre-
lates (12,13,17-19). While anobligatory role can bejus-
tified in the case of uterine development, the role of
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these same hormones in embryo development is not
secure. Whith only asingle exception (20), invitro blas-
tocyst differentiation has been reported to proceed pro-
grammatically in the absence of steriod hormones
(21,22).
Based on these earlier studies, we now possess a
reasonable understanding of the conditions necessary
to coordinate events within the female reproductive
tractthatbringtheembryointotheuterineenvironment
with the maximum opportunity for implantation (13,
14,19,23). However, these data are not adequate to de-
fine the cause-and-effect relationships thatare the basis
for the specific actions of hormones, drugs, and toxic
agents. The questions now arising go beyond these his-
toric approaches. In order to define the regulatory bi-
ology of blastocyst-endometrial interactions and how
theymaybealteredbyxenobioticagents, itisnecessary
to bring new, more incisive methods developed in other
disciplines, i.e., cell biology, immunology, molecular bi-
ology, etc., to bear on these investigations.
The placement ofthe trophectoderm (TE) cells ofthe
blastocyst inintimate contactwiththereceptive uterine
endometrium initiates the progressive phases ofthe im-
plantation process (19,21,23). It is suggested that these
phases are programatically directed by information ex-
changed directly via cell-cell communication (24), but
alsomodulated bydirective andpermissive signalsfrom
stromal-epithelial intercommunication (25). These in-
formational molecules are expressed in response to the
same steroids which synchronized the blastocyst and
uterus from the beginning.
In order to interpret specific implantation events in
terms ofcell-cell interactions, we have developed meth-
ods for the separation of homogeneous populations of
the individual cell types involved directly in implanta-
tion(endometrial epithelialandstromalcells, blastocyst
trophectoderm, and ectoplacental cone cells and troph-
oblast giant cells). We have also developed methods for
the in vitro culture ofthese individual cell populations
so that we can begin to analyze the biochemical mech-
anisms which regulate their differentiation and thereby
their interactions (27-30).
To apply the concept ofbiomarkers to the interaction
of xenobiotics and those processes that define early
mammalian development, we formulated a specific re-
search strategy. The plan is necessarily dependent on
animal experimental models. The first goal of the plan
is to identify markers causally related to events critical
to embryo-uterine interactions. Cellular and biochemi-
cal methods have been developed to identify and vali-
date structural and/or functional markers of the regu-
latory processes involved in the differentiation of each
component (28-30). Construction ofsuch a directory of
experimental markers provides a focus to select the
most reasonable candidates that could be examined in
modes applicable to a nonlaboratory environment. The
evolution of this strategy, which necessarily begins in
the laboratory, enhances the feasibility ofapplying the
conceptualtriad ofenvironmental, biological, andhealth
monitoring to the action of xenobiotic agents on early
development. For the purposes ofthis essay, we have
chosen to discuss differentiation ofthe trophoblast (tro-
phectoderm) of the blastocyst to demonstrate the pro-
ductivity ofthis research strategy.
Trophectoderm
The first cells to differentiate in the mammalian em-
bryo are the trophectoderm (TE) cells. This commit-
ment occurs at compaction of the cleavage stage em-
bryo, at which time the blastomeres assume an inside-
outside orientation (31). Although trophoblast cells do
not contribute to the formation of the embryo, they
become anintegral part ofthe placenta (21). TE and its
differentiated derivatives(trophoblastgiantcells, TGC)
are intimately involved not only structurally, but in
most ofthe functions ascribed to the placenta, and are
criticaltoviviparity (32). Thus, compactionandthesub-
sequent process ofblastocoelation are critical processes
atwhichtheadverseeffectoftoxicagentscouldprovoke
far-reaching influences on development.
In utero the mammalian embryo is comprised of an
inner cell mass (ICM), the presumptive embryo, and a
blastocoel; both are surrounded by an outer covering of
trophoblast (TE) cells. The TE cells which cover the
ICM are termed polar TE, while those which surround
the blastocoel are termed mural TE. Preimplantation
and early postimplantation TE cells are proliferative
and diploid (2-4 c).
When trophoblast cells lose contact with the ICM (or
attach to the uterine epithelium), they lose their ability
to divide. Unlike somatic cells which remain diploid
after they cease to divide in G2, the trophoblast cell,
which also ceases division in G2, becomes a giant cell
and increases the DNA per cell (33). In the human this
increaseinDNA/trophoblastcellisaccomplishedmainly
by cell fusion (cytotrophoblast--syncytiotrophoblast).
In the mouse and the rat the increase in DNA/cell is
nuclear. It takes place via endomitotic and endoredu-
plicative mechanisms (34) and not by fusion (33).
Inutero blastocyst attachment (adhesion) is an initial
step in implantation. It is important because it signals
the start of those processes of differentiation which
manifestthemselves inthe establishment ofa definitive
placenta. A highly regulated program ofstructural and
functional differentiation is expressed duringthe inter-
val defined by the attachment of blastocyst TE to re-
ceptive uterine epithelium and the apposition of TGC
with elements of the maternal vascular system
(19,21,23). These modifications in trophoblast function
(Table 1) support the viability and the ordered patterns
of embryonic growth and development. Progression of
trophoblast through the remodeled substrate of the
uterine decidual cells is assured by the secretion of el-
evated titers of progesterone by either the corpus lu-
teumorthetrophoblast cells. Sincethemammalian spe-
cies vary from each other at each step in the process of
establishing the placenta, the studies reported here are
limited mainly to rats and mice.
On the basis of preliminary studies, mainly in the
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Table 1. Biochemical markers of trophoblast differentiation
expressed during the peri-implantation period.
Class Type
Deciduogenic stimulus Initiates stromal cell
differentiation (decidualization)
Endocrinological Steroids (estrogen, progesterone,
testosterone)
Peptide hormones (hCG, rPL-1)
Releasing factors
Immunological Trophoblast recognition antigens
Invasiveness (controlled, self- Cytoskeletal
limiting) (adhesion-- migration)
Matrix remodeling enzymes
Cytolytic enzymes
Phagocytosis
mouse (21-23), it was determined that of all the possi-
bilities (Table 1), monitoringthesynthesis and secretion
ofthe steroidhormones andthepeptidehormoneswould
provide the best opportunities to identify markers
unique to the differentiation ofTE. The subjects ofour
initial studies wereratblastocysts and theirtrophoblast
outgrowths cultured in vitro.
In Vitro Culture of Rat Blastocysts
and Trophoblast Outgrowths
We have cultured rat blastocysts recovered from the
uterus on day 4 ofgestation (day ofimplantation). Blas-
tocysts were cultured in groups of 10-20/35 mm culture
dishes in 3 mL of NCTC-135 (Gibco) plus 10% heat-
inactivated fetal calf-serum (FCS) and 1% streptomy-
cin-penicillin. Cultures were maintained at 37°C in a
humidified atmosphere of 5% CO2 in air. Spent media
was collected daily for analyses (35). Under these con-
ditions the inner cell mass persists for only 60 to 72 hr,
while the trophoblast tissue remains viable and contin-
ues to grow.
Steroidogenesis
Highly specific radioimmunoassays were used to de-
termine progesterone, estradiol, andtestosterone inthe
same sample of spent blastocyst media (23,35). Media
without blastocysts provided control measurements.
Rat blastocysts secrete significant amounts of pro-
gesterone (0.1-0.5 pg/mL/blastocyst) during the initial
phases of hatching (equivalent gestation day, EGD, 5)
and outgrowth (EGD 6), increasing to 6 to 7 pg/mL/
blastocyst (EGD 8-13) (Fig. 2). Progesterone then falls
to a lower but still significantly elevated value (4.5 pg/
mL/blastocyst) from EGD 14. The patterns ofestradiol
and testosterone by the rat blastocyst and trophoblast
outgrowths can also be demonstrated (Fig. 2). The pat-
terns ofsecretion ofthese latter two steroids have been
too erratic to serve as reliable markers of trophoblast
differentiation.
It is of interest to note that the production of pro-
gesterone by rat blastocyst trophoblast outgrowths oc-
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FIGURE 2. Steroid production by rat blastocyst outgrowths. Day
4 blastocysts (sperm positive = day 0, onset of pregnancy) were
recovered from the uterus and cultured in groups of 10-15 in 3
mL NCTC-135 plus 10% fetal calfserum in 35 mm plastic dishes.
Medium was changed daily. Hormones were assayed by specific
radioimmunoassay of spent medium. Equivalent gestation
day = the age ofthe blastocyst in culture equivalent to the age it
would have been if left in utero (23).
curs at the time during gestation (EGD 6-8) when
plasma progesterone of the pregnant mother has al-
ready increased to values approaching 60 ng/mL (23).
Maternal plasma progesterone plateaus at 90 to 120 ng/
mL between EGD 10-12. In the presence ofthis great
pool of maternal plasma progesterone, no role has yet
to be identified for the progesterone (or estradiol and
testosterone) contributed by the trophoblast cell. Pos-
sibly, trophoblast progesterone (as contrasted with the
progesterone from the corpus luteum) plays a paracrine
role in the ontogeny ofdecidual cell differentiation and/
or an endocrine role in the trophoblast regulation of its
estradiol receptor (36) or rat placental lactogen synthe-
sis (30). Iftrophoblast steroidogenesis does have some
regulatoryrole, itremains tobe determined howcritical
this progesterone is to developmental programs and the
relative sensitivity of trophoblast steroidogenesis to
toxic insult compared to steroid hormone production by
the corpus luteum.
Trophoblast (Placental) Peptide Hormones
At midpregnancy in the rat (EGD 11), the control of
luteal progesterone secretion shifts from the pituitary
to the placenta (37). The maintenance ofthe second half
of pregnancy is dependent on the luteotropic and lac-
togenic activity of placental secretions. A hormone of
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placental origin with both activities was identified in the
serum of midpregnancy rats (38). Subsequently it has
been shown that the hormone from placental extracts
(lactogen) demonstrates two peaks of activity. A pla-
cental hormone with luteotropic activity was first de-
tected in placental extracts at EGD 11. A second peak
observed on EGD 16to 17waslactogenic andessentially
devoid ofluteotropic activity. It is now recognized that
these two peaks ofactivity represent the production of
two distinct peptide hormones synthesized by the pla-
centa of both mice (39) and rats (30).
Since the presence of placental peptide hormone(s)
prior to EGD 11 had not previously been reported, it
became of interest to determine if trophoblast out-
growths of day 4 rat blastocysts would differentiate in
culture to express placental lactogen (4 + 6-7 days).
The presence of small but detectable amounts of pla-
cental lactogen in the spent medium of rat blastocyst
cultures at EGD 6 to 8 was surprising but rational. The
production of placental lactogen by blastocyst out-
growths peaks on EGD 9 and then decreases with time
in culture (Fig. 3). It was not possible using the radi-
oreceptor assay (40) and other tests available at that
time to distinguish whether this secretory product rep-
resented only the early luteotropic activity or was a
mixture of both activity peaks. Nor could it be deter-
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FIGURE 3. Ratplacentallactogen (rPL) assayedby aradioreceptor
assay (40) and expressed in terms ofovine prolactin (oPRL) equiv-
alents. Blastocysts were recovered from uteri on day 4 and cul-
tured in groups of 15/35 mm culture dishes in 3 mL NCTC-135
medium. rPL was measured in 24 hr spent medium. Trophoblasts
(mural, polar) were dissected from conceptuses on EGD 9. Troph-
oblasts from 15 conceptuses were cultured in vitro and rPL was
assayed on 24 hr spent medium.
mined which particular cell type was the source of se-
cretion.
To help resolve the issue of specific cell site of pla-
cental lactogen secretion and improve the utility ofthis
model as a monitor for the action of xenobiotic agents,
trophoblast cells were dissected from rat embryos at
day 10 of pregnancy. The majority of separated cells
was composed of primary and secondary trophoblast
giant cells, but included representatives of polar tro-
phectoderm and ectoplacental cone cells and their de-
rivatives. After harvest the cells were dissociated in
Dulbecco's PBS lackingCa2" containingtrypsin (0.5%)-
EDTA (0.2%) plus 200 units DNAse before culture
(26,27). The same radioreceptor assay used to study
placental lactogen (PL) production by rat blastocysts
was used to estimate hormone production by tropho-
blast cells. Under these conditions the peak production
by day 10 trophoblast cells occurs at EGD 11. The peak
value (Fig. 3) represents secretion of a PL hormone of
almost300ng/day/trophoblast; avaluegreaterthanthat
expected on the basis of plasma titers.
The loss of secretory capability in either culture sit-
uation (Fig. 3) cannot be explained at this time, but the
possibilitythatthislossisduetocultureconditionsmust
be considered. Equally unexplained are the differences
between the secretory physiology of blastocyst out-
growths and trophoblast cells. Not only were the peaks
of PL activity expressed at different times, but troph-
oblastcellshavesignificantly greatersecretorycapacity
thanblastocystoutgrowthsatequivalentdevelopmental
ages (approximately 100-fold at EGD 11). These differ-
ences may be related to the gestation age at which the
cell or its progenitor was placed in culture. However,
the data argue in favor of some regulatory factor(s)
operable in vivo between EGD 4 and 10 that may con-
tribute to the capacity of trophoblast cells to secrete
PL in sufficient titers to maintain luteal steroidogenesis
by EGD 11 when pituitary factors have been with-
drawn. If such factors exist, they have not yet been
identified, but their existence suggests an important
control point that could be perturbated by toxic agents.
These datasuggestedfurthertwomodifications inthe
research plan. The first was to focus attention on the
secretion of the placental hormones because of the im-
portance of their putative actions and their apparently
specific relationship to the trophoblast cell. Emphasis
was placed on PL secretion and its specific secretory
cell, rather than continuing analysis of progesterone.
The decision was based on observations that proges-
terone synthesis was not exclusive to trophoblast and
no leads to the function of trophoblast progesterone
exist. The second modification was to enhancethe study
of PL by improving the methods used to separate the
suspected endocrine-competent trophoblast giant cells
from their undifferentiated trophectoderm and ectopla-
cental cone percursors.
Trophoblast Giant Cells
Differentiation of the fetal placenta is essential to
embryonic development in mammals. In rodents the
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trophoblast giant cells are an integral component ofthe
fetal placenta. In vivo and in vitro primary and sec-
ondaryTGC derivefrommuralandpolarblastocyst TE,
respectively. Cells ofthe ectoplacental cone (EPC) de-
rive from polar TE (33) and serve as precursors for
additional secondary TGC. TGC cease to divide as a
primary step in their differentiation from TE or EPC.
Aproportion (15-25%)oftheTE cellsbecomebinucleate
ormultinucleate. Morphologically TGC arenondividing,
polytene giant cells. The c number (haploid DNA) in
TGC increases from2to4 to as much as 1024 as aresult
of endoreduplication (41). In human trophoblast cells
only a fraction (estimated at no more than 40%) become
endoreduplicative (42). DNA content ofendocrine-com-
petent human trophoblast cells increases by fusion or
syncytialization ofcytotrophoblasts, rather than by en-
doreduplication. Functionally, TGC express secretory
programs for proteolytic enzymes (proteases, collagen-
ases, elastases), steroid hormones (progesterone, tes-
tosterone, estrogen), andatmidgestation apeptidehor-
mone(s), placental lactogen(s) (Table 1). Rodent troph-
oblast, unlike human, does not appearto produce a cho-
rionic type ofgonadotropin.
Placental Hormones
Placental peptide hormones display characteristics
similar to pituitary prolactin (PRL) and growth hor-
mone (GH). For this reason they have been termed
placental lactogens (PL) or chorionic somatomammo-
tropins (43,44). PL is the dominant trophic hormone
affecting fetal development during the latter half of
pregnancy (45). PLs may directly regulate the devel-
opment of fetal tissues, as demonstrated by the stim-
ulatory actions ofovine PL on amino acid transport and
ornithine decarboxylase activity in fetal tissues (46,47),
or indirectly, via alterations in maternal protein, car-
bohydrate, and lipid metabolism (48).
Thebiology andbiochemistry ofPLs varyamongspe-
cies, but all appear to share a common feature. They
are secretory products of placental giant cells. In the
human, PLhasbeenlocalizedtothesyncytiotrophoblast
(49), in sheep, to the trophoblast binucleate cells (50-
52) and in the rat, to the trophoblast giant cells (30,35).
ThesePL secretorycells differentiatefromreadilyiden-
tifiable precursor cell populations: human, cytotropho-
blast (53), sheep, uninucleate cells (54); mouse, tro-
phectoderm and ectoplacental cone cells (33,55).
Trophoblast giant cell differentiation has not been rig-
orously studied. The mostthoroughinvestigations have
been done in the rodent, primarily the mouse, in which
Rossant and her co-workers (55-57) have analyzed the
transformation of ectoplacental cone cells to differen-
tiated trophoblast giant cells.
The rat and mouse produce two types of PLs (30,
58,59). These hormones can be distinguished biochem-
ically, immunologically, and by their temporal appear-
anceduringpregnancy. Theearlyform(PL-1)ispresent
duringmidpregnancy (days 9-11 inthe mouse; days 10-
12 in the rat), and the late form (PL-2) predominates
during the latter half of pregnancy. PL-1 has a larger
molecular weight and is a more acidic protein than PL-
2(30). Both areactiveinradioreceptorassaysandbioas-
says for lactogenic hormones (30); however, neither is
active in agrowth hormone radioreceptor assay. Serum
PL-2 levels have been measured in the mousethrough-
out pregnancy and during the periparturitional period
(60,61). The ovaries have an inhibitory influence on
serum PL-2 levels, while the fetus has a trophic influ-
ence (62). Distinct genetic differences in the serum pro-
files ofPL-2havebeenreported (60). Inaddition, serum
PL-2 levels appear to be elevated in genetically dwarf
mice, implicating a role forthe anterior pituitary in the
regulation of serum PL-2 levels (63). That PL was a
product of the trophoblast rather than other compo-
nents of the placenta was first demonstrated by the
previously discussed studies of PL production by blas-
tocyst trophoblast outgrowth. In order to show more
directly that TGC, per se, were the site of placental
hormone production, the cells were dissected as essen-
tiallyhomogeneous singlecell-type populationsfromrat
conceptuses atgestationdays9, 10, 11, or 12(27,28,30).
Foreach conceptusthe TGC were separated into mu-
ral and polar giant cells. A third group ofcells, central
TGC, was established to avoid mixing ofthe mural and
polar samples at the time of dissection (Fig. 4). The
methods for dissection and culture have been described
previously (27,28,30). The rPL proffile of spent culture
media was characterized by gel filtration chromatog-
raphy and SDS-gel electrophoresis. The relative activ-
ity of media fractions was determined by the prolactin
radioreceptor assay (40).
Inutero, mural TE are the first to cease cell division.
They begin to differentiate into primary trophoblast
FIGURE 4. Schematicdiagram ofamidpregnantratconceptus. The
dashed lines indicate the regional limits ofdissection for the har-
vest of the individual groups of trophoblast giant cells (30). This
diagram is based on information presented by Davies and Glasser
(65).
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giant cells as a consequence oftheir attachment to the
receptive uterine epithelial cells ofthe antimesometrial
uterus. Polar trophectoderm cells remain diploid and
continue to proliferate as the embryo elongates during
formation ofthe eggcylinder (33,64). Approximately48
to 60 hr later, as proliferative pressure moves polar TE
cells away from the ICM and they begin to attach to
the mesometrial epithelial cells, the polar TE cease to
divide. Theybegintodifferentiateintosecondarytroph-
oblast giant cells. The existence of two placental lac-
togens with different peaks of activity and two appar-
ently related different TGC suggested that 10 TGC
might be the source of the early PL (rPL-1) and that
the later rPL-2 was a secretory product ofthe 20 TGC.
If this were proven then there might possibly be two
separatetargets, eachwithitsunique secretoryproduct
and each with possibly a different sensitivity to xeno-
bioticagents. ToexaminetherelationshipbetweenTGC
types and rPL-1 and rPL-2, the different populations
of TGC were dissected free from the rat conceptus on
either gestation day 9, 10, 11 or 12. The spent media of
in vitro cultures was monitored for the qualitative se-
cretion of the placental lactogens.
Analysis of 24 hr spent medium from mural, polar,
and central TGC of day 11 rat conceptuses (Fig. 5)
showed that the ratio ofPL-1 to PL-2 released by TGC
was similar, regardless of their location in the concep-
tus. On any one developmental day, the only regional
differences arequantitativeratherthanqualitative. The
output of total PL and of testosterone by mural TGC
was almost three times greaterthan polarTGcells (30).
Mural TGC output of progesterone was approximately
eightfold greater than polar TGC.
The type of PL released by TGC proved to be cor-
related with the day ofdevelopment. Thus, TGC placed
inculture onEGD 10releasepredominantlyPL-1, while
TGC cells isolated on EGD 11 release predominantly
PL-2. This transition is reflected in plasma patterns.
This switch from PL-1 to PL-2 which occurs in vivo
cannot be reproduced under the in vitro conditions cur-
rently in use (Fig. 6).
Differences in the quantity of hormone production
could be an effect oflocal environment, i.e., polar TGC
interface with maternal decidua basalis and the mes-
enchymally induced trophospongiosum of the chorioal-
lantoic placenta, while mural TGC are situated between
the decidua capsularis and the parietal endoderm (65).
Production couldbemediatedbysignaldifferences from
the different environments and/or their interpretation
by the respective TGC. This suggests that residual ef-
fects of xenobiotic agents in undifferentiated uterine
stromal cells might exercise some influence on tropho-
blast endocrine function when these cells later deci-
dualize. The absence ofqualitative regional effects con-
firms that all TGC are essentially similar; functional
differentiation of an individual TGC results in the se-
quential expression ofPL-1 and PL-2 by the same cell.
Thusthereis only one, nottwo, trophoblast targets and
the response of that target to toxic exposure is relev-
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FIGURE 5. Elution profiles ofspent mediafrom day-11 trophoblast
giant cell cultures. The trophoblast giant cells were isolated from
polar, central, and mural regions of the conceptus (Fig. 4) and
incubated for 24 hr. These elution proffles were obtained by gel
ifitration of samples on Sephadex G-100. The rPL activity of the
eluates, expressed in terms ofoPRL equivalents, was assayed by
the PRL radioreceptor assay (40).
antly influenced by the developmental stage at which
the trophoblast cell is placed at risk.
TGC Cytoskeleton
Because morphological and functional differentiation
have been linked to alterations in the expression ofcy-
toskeletal proteins, we have analyzed microtubules and
intermediate filaments in endocrine-competent TGC
(66) in order to identify additional markers.
Microtubules. Tubulin and polymerized microtu-
bules have been identified in TGC, but the microtubule
organizing center (MTOC) has yet to be described.
When TGC (day 10 + 48 hr in vitro) were cultured in
the presence of colcemid (0.06 ,ug/mL), their microtu-
bules were completely disrupted by 4 hr. Preliminary
studies showed a 75% decrease inthe production ofrPL
over the next 24 hr. Indirect immunofluorescent stain-
ing revealed multiple punctate sites interacting quali-
tatively with human autoantibodies to centrosomes,
with antibodies to purified tubulin, but not kinetochore
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FIGURE 6. Elution profiles ofspent media from day-10 and day-11 trophoblast giant cell cultures. The trophoblast giant cells were dissected
from the mural region ofthe conceptus (Fig. 4) and cultured for 48 hr (upper panel: 0-24 hr: lower panel: 24-48 hr). Media was harvested
at 24 hr intervals and chromatographed on Sephadex G-100. The rPL activity of the eluates was assayed using the PRL radioreceptor
assay (40).
antibodies. These sites occur throughout the cell; they
were located in the perinuclear position where cen-
trioles, which conventionally serve as MTOCs, are
found. Removal ofcolcemid resulted in the reassembly
the cytoplasmic microtubule complex coincident with a
60% recovery in rPL production during the next 24 hr.
Under reassembly conditions, tubulin repolymerizes at
each of the multiple cytoplasmic sites. Thus TGC from
TE are unlike most other cells. They possess a decen-
tralized system for microtubule renucleation occurring
at multiple sites throughout the cytoplasm. Microtu-
bules may represent a sensitive and ubiquitous target
forxenobiotic agents. Disruption in microtubule assem-
bly could have far-reaching effects on cell function.
Intermediate Filaments. In rodents, TE are the
first embryonic cells to exhibit intermediate filament
proteins (66). Mouse preimplantation blastocyst TE dis-
played two intermediate filament proteins (54 Kd, 46
Kd)identifiedascytokeratins. Incontrast, midgestation
TGC displayed not only the 54 Kd and 46 Kd interme-
diate ifiament proteins, which were major components
of their cytokeratin proffles, but 52 Kd, 45 Kd, 43 Kd
and 40 Kd species. Ofthese additional keratins, the 52
Kd and 40 Kd were more prominent (28).
Analysis by two-dimensional polyacrilamide gel elec-
trophoresis, partial proteolytic digests, coupled with
immunoprobing ofWestern blots and with indirect im-
munofluorescence stainingofTGC, showedthatthecon-
stitutive intermediate filament proteins were cytoker-
atins and that this proffle is shared by simple epithelial
celltypes(vs. stratifiedsquamous)representedbyliver,
lung, pancreatic islets, parietal endoderm, and uterus.
Detectable amounts of the 52 and 40 Kd keratins are
found in day 9 TGC; the entire complex is present in
day 12 TGC. During this transition period, the individ-
ual cytokeratin species elaborate isoelectric variants.
Relative to total protein, intermediate filament protein
increases over the same period. This increase in inter-
mediate filament protein is reflected by indirect im-
munofluorescence staining. Indirect immunofluores-
cence arrays display an increase in the profusion and
complexity of the cytokeratin filament network in day
11 and 12 TGC compared to day 9 TGC and blastocyst
outgrowths. While no specific function has yet been as-
signed to any of the expressed proteins of the various
cytokeratin gene families, these additional landmarks
may eventually come to be ofsignificance in monitoring
the functional and morphological differentiation ofspe-
cialized cells (67), i.e., EPC cells and other stem or
precursor cell populations.
In vitro analysis of the morphological and functional
differentiation of blastocyst outgrowths and isolated
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TGC have been effective in terms of identifying valid
biological markers of processes essential to establish-
ment ofthe fetal placenta. While other markers (Table
1) have not been discounted, these experiments have
recognized placentallactogens astheunique candidates.
Identification of the differentiated trophoblast cell
(TE-*TGC) as the single cellular source of these hor-
monesis also animportant observation. Furtherstudies
to assess the risk of a presumptively pregnant female
can now focus on the development of the trophoblast
and its expressed secretions.
The expression of PL-1 during the period of organ-
ogenesis may be only coincidence, but the possibility
that PL-1 and organogenesis may be more closely re-
lated, possibly via a reciprocal relationship with insulin
growth factors (68), suggests that in spite ofthe poten-
tial for repair (endoreduplication of DNA, transforma-
tion of ectoplacental cone cells), early exposure of an
individual (from the determination ofTE at compaction
throughtheinitialturn-onofthePLgenes)mayproduce
consequences more reaching than ifexposure occurred
as TGC differentiation (and organogenesis) was termi-
nating (relative to the onset of the period of fetal
growth).
These data give rise to a number of questions that
should be resolved before research strategies designed
to evaluate the use ofthese markers as health monitors
can be used. The implied importance of DNA adducts
(69) suggests that the relationship of increased DNA
per trophoblast cell to the expression of PL hormones
and other developmental programs may be critical in
theresponseofthetrophoblast celltoxenobiotic agents.
This is a difficult issue to resolve because TGC are al-
most terminally differentiated at the time of harvest,
and neither TGC nor the outgrowths provide sufficient
biological material for analysis.
Ectoplacental Cone Cells
Ectoplacental cone (EPC) cells arise from polar TE.
They are diploid and proliferative. Because of their
numbers and because they endoreduplicate and differ-
entiate in culture, they represent a model that could
resolve some ofthe questions posed in previous exper-
iments. Mouse EPC cells (Fig. 7) transplanted ectopi-
cally orcultured invitro transformintogiant cells. Ros-
sant and her colleagues (55-57) have analyzed the
transformation of EPC cells to differentiated tropho-
blast giant cells (TGC). Mouse EPC cells transplanted
ectopically orcultured invitrotransformintogiant cells
(57). The transformed giant cells endoreduplicate their
nuclear DNA; they are polyploid and synthesize pro-
teins that are characteristic ofTGC vis-a-vis EPC (57).
The presence ofthe innercellmass adjacent tothe EPC
cells isbelieved tomaintainthemin aproliferative state
andinhibitthetransfornation toTGC(56). Asgestation
progresses, some EPC cells are pushed further from
the inner cell mass orits derivatives and transform into
TGC. Thus, EPC cells serve as areservoir ofprecursor
cells that contribute to the growth and expansion of
trophoblast during the second-half of pregnancy.
While it has been demonstrated that TGC derived
from TE produce steroid and peptide hormones (23), a
question arose as to whether all giant cell derivatives
of trophectodermal origin acquired endocrine compe-
tence. Thus, if EPC are, in fact, a precursor reservoir
for giant cells, can these morphological and biochemical
transformants also subserve the critical functional role
of the 10 and 2° trophoblast giant cells, the production
of PL?
Ectoplacental cone cells can be harvested (Fig. 7)
from rat conceptuses on days 9 to 12 of pregnancy,
cultured in vitro and observed to change. A proportion
become bi- or multinucleate (Fig. 8). The majority of
cells become giant, polyploid, and endoreduplicate dur-
ing the culture period (Figs. 9 and 10). Endoredupli-
cation of rat EPC cells in vitro mimics the patterns
observed when mouse EPC (57) were placed in culture.
Ectoplacental cone cells obtained from days 9 to 12 of
gestation all show similar morphological and constitu-
tivebiochemicalchanges duringtheirtransitiontoTGC.
Functionally, EPC cells from day 12 conceptuses be-
come giant cells that are capable of producing PL-2
(Figs. 11 and 12). For a number of technical reasons,
including the lack of an accurate, sensitive radioim-
munoassay, we have not yet been able to unequivocally
identify the secretory product elaborated by cultures of
day 10 EPC cells. Ofpotential far-reaching importance
has been the observation (Munir and Glasser, in prep-
aration) that no PL can be detected by the PRL radi-
oreceptor assay in either cultures of day 10 or day 12
EPC until the second round of endoreduplication has
been completed (Fig. 13). The unavailability of specific
probesdoesnotpermitustodetermineifPLisaproduct
expressed only by trophoblast cells of8n or greater, or
whether this event represents some critical change in
the microenvironment ofthe culture.
Pre- and postimplantation precursor cells are diploid
and dividing (56,64). When these cells lose contact with
the inner cell mass and its derivatives (54,56), they lose
their ability to divide and become giant with nuclear
DNA contents greater than 4c. The mechanism of nu-
clear DNA replication in the rodent TGC is via endo-
reduplication (34,41,70,71). Using available methodol-
ogy, Shermanetal. (70)concludedthattheaccumulation
of DNA in the TGC was not due to a disproportionate
amplification of satellite sequences. Constancy in the
ratio of satellite to main band DNA implied that all
genes are replicated to the same extent; specific genes
were not being amplified, nor was satellite DNA being
underreplicated.
Very little information has been developed since the
adventofrecombinant DNAmethodologyregardingthe
organization of the TGC genome or gene expression of
genomic DNA which can increase from 2 to 1024e. Ex-
tensive endoreduplication during the course of normal
differentiation make TE, EPC, and TGC unique mam-
malian cells and thereby unique models to study gene
expression. Analysis of interspersed repetitive DNA
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FIGURE 7. Schematic representation of the mouse embryo at 5.5 and 7.5 equivalent gestation days. Adapted from Johnson and Rossant
(57). Dissection of day 10, 11, and 12 EGD rat ectoplacental cone cells was guided by the diagram of the 7.5 day mouse embryo.
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FIGURE 8. The mitotic index of ectoplacental cone cells isolated from EGD 11 rat conceptuses. EPC cells were cultured in plastic culture
dishes in either NCTC-109, or unattached over agarose pads. The number ofnuclei per cell was plotted over the same period and expressed
as a fraction of the entire study population.
sequencearrangement correlated withtheintricate pro-
gram of differential biochemical expression of endore-
duplicated TGC DNA offers a unique opportunity to
study the cellular and molecular basis ofdifferentiation.
Regulation of Trophoblast Hormone
Synthesis
Relative to the successful regulation ofearly postim-
plantation interactions between the embryo and the de-
cidualizing stroma, what advantage is nuclear DNA en-
doreduplication (or syncytialization) to giant cell
differentiation? Evenifmodern recombinant DNAtech-
nology confirms that PL expression is a correlate of
replication ofthe entire trophoblast genome ratherthan
amplication (41,70), we are left with relevant unan-
swered questions. We still must seek the signals that
initiate PL-1 synthesis in the enlarging genome, that
direct the sequence rearrangements obligatory for the
PL-1 to PL-2 transition, and that initiate PL-2 synthe-
sis. These questions are applicable to analysis ofhuman
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FIGURE 9. Histogram of cytophotometric analysis of Feulgen-
stained DNApernucleusinectoplacental cone (epc) andsecondary
trophoblast giant (TGC) cells freshly dissected on EDG 11. The
values for control, 2c, 4c, and 8c amounts ofDNA were obtained
from control liver samples.
trophoblast, for they identify regulatory foci coincident
to differentiation ofcytotrophoblast at which point xe-
nobiotic agents could interrupt or redirect normal de-
velopment.
There is not much more useful data known about the
biochemical or physiological regulation ofPL synthesis
and secretion. This situation is not due to lack ofwork
but rather due to the types of experiments conducted.
Only recently has research veered from the analysis of
animals, whole tissues, or complex populations of het-
erologous placental cells. The secretion ofPL-2 is influ-
enced by the presence of the fetus (stimulatory) and
ovarian and adrenal steroids (inhibitory) (72). When rat
fetuses are removed from the placenta (fetectomy) (65)
at day 14, serum PL-2 levels are markedly depressed.
The stimulatory role of the fetus was confirmed in a
report that established the requirement for progester-
one in maintaining PL-2 secretion and suggested that
PL-1 terminates PRL surges atmidpregnancy (73). Al-
though the absence of progesterone may arrest PL-2
secretion, its effect may depend on the presence of a
particulartarget cell. Ofinterestis ourobservation that
progesterone, 1 x 10-6M, inhibited (75-80%) PL-2 pro-
duction by terminally giant cells differentiating from
day 12 EPC, but did not influence PL-2 production by
differentiated TGC (Fig. 14) (Soares and Glasser; Munir
and Glasser, unpublished observations). Identification
of the mechanism of progesterone regulation and the
basis for the differential response ofday 11 vs. 12 EPC
depends on molecularprobes that are not yet available.
Extrapolation to Human Trophoblast
The experiments with in vitro models oftrophoblast
cells have proven productive. These studies have iden-
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FIGURE 10. Histogram of cytophotometric analyses of Feulgen-
stained DNA per nucleus in freshly dissected EGD 11 (t = 0) rat
ectoplacental cone cells. Cells were placed into culture and the
DNA percell analyzed after +2d and +4d. Theendoreduplicative
shift in DNA/nucleus correlates with increases in nuclear and cy-
toplasmic volumes in this nondividing cell population.
tified the importance of the postmitotic differentiation
of a particular class of epithelial cells, i.e., the tropho-
blast cell and its derivatives, in the control of normal
mammalian development. Markers of structural and
functional events critical to this problem of differentia-
tion have also been reported (28-30). It is appropriate
to ask whether these results can be extrapolated to the
analysis of early human development. Second, would
such extrapolation improve our understanding of the
early communication between the human embryo and
the maternal host to the point ofidentifying markers to
monitor exposure to xenobiotic agents?
It should be recognized that while the rodent tropho-
blast experiments have enlarged our understanding of
certain aspects ofpostimplantation biology, they have
not yielded markers that could reliably signalthe status
of the trophoblast during the high risk pre- and peri-
implantation period in either mouse, rat, or human.
These species represent animals in which the residence
time ofthe free blastocyst inutero is rather short. This
time is in contrast to certain farm animals (sheep, pig,
cow) in which the uterine residence time of the free
blastocyst is long (> 12 days) and the blastocysts syn-
thesize and secrete gonadal signals which mark the im-
mediate preimplantation period (74). Suggestions that
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FIGURE 11. rPL production by ectoplacental cone cells dissected
from EGD 12 rat conceptuses and cultured in vitro in NCTC 109.
rPL, expressed as o-PRL equivalents, was assayed in spent me-
dium by radioreceptor assay.
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FIGURE 12. Gelchromatographicanalysis(SephadexG-100)ofspent
medium from rat ectoplacental cells (EGD 12) cultured in vitro.
The Ve/Vo ratio of 2.1 established the active fraction as rPL-2
(Fig. 5).
the short in utero residence blastocysts also generate
steroid implantation signals (75) have not been con-
firmed (74).
A practical marker of postimplantation trophoblast
development in the human does exist. The radioim-
munoassay of chorionic gonadotropin (hCG) provides
useful general information. In an effort to identify ad-
ditionalmarkersthatprovide morepreciseandsensitive
indices of early human gestation, investigators have
called on contributions from immunochemistry, bio-
physics, andbioengineering. Wewouldaskifourstudies
in cell biology also contribute to these efforts in any
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and EGD 12ectoplacentalconecellsasafunctionoftimeinculture.
ThetimewhenrPLisfirstdetectedbyoPRL-RRAisnoted. Three
separate experiments are represented by these data.
Influence of Progesterone on in vitro Production of
Placental Lactogen by Undifferentiated
and Differentiated Trophoblast Cells
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FIGURE 14. The in vitro production of rPL by undifferentiated
trophoblast cells (EGD 12 ectoplacental cone cells) is down-reg-
ulated by the inclusion of progesterone in the culture medium
(upper panel). The same culture conditions have no influence on
the relative rPL production by terminally differentiated tropho-
blast cells (EGD 12 trophoblast giant cells; lower panel).
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way; either in reevaluating the usefulness of existing
markers, i.e., hCG, or providing directions to the dis-
covery of new ones.
Human Chorionic Gonadotropin as
a Marker
Humanchorionicgonadotropin (hCG)istheconfirmed
practical marker fordevelopment ofhuman trophoblast
cells. hCG is a glycosylated (30%) peptide hormone
(M.W. 36,700). The hormone is composed of two non-
identical subunits that are noncovalently linked. The a
subunit is similar to the a subunits in FSH, LH, and
TSH, differing from the others only in its carbohydrate
composition. The P subunitofhCGisresponsible mainly
for conferring biological activity. ,B-hCG differs from ,B
subunits of FSH, LH, and TSH both in its amino acid
and its carbohydrate composition. Both subunits are
required for biological activity, as neither subunit alone
binds to hCG receptors. Specific antibodies have been
raised against the a and 1 subunits and the intact hor-
mone. Radioimmunoassays of increasing specificity,
precision, and accuracy have been used to measure
plasma levels ofhCG (76,77). The major recognized ac-
tionofhCGisitsroleintheregulationofsteriodogenesis
in the corpus luteum. Thus, hCG serves a pivotal func-
tioninthemaintenance ofpregnancy. hCGhasalsobeen
implicated in the regulation of steriodogenesis in the
fetal testis and possibly the fetal adrenal. Its role in the
regulation ofplacental steriodogenesis is controversial.
The widespread use of the radioimmunoassay (RIA)
for hCG derives from the ready availability of specific
antibodies at reasonable cost, the relative ease of the
assay, the extensive background on interpretation of
plasmatiters, plus the absence ofandthe need formore
specificmarkers. The RIAforhCGhasreceived general
acceptance as anindicator ofpregnancy and some ofthe
pathophysiological events that may be associated with
it. The biological rationale for the hCG-RIA is that a
rise in plasma hCG reflects the presence ofa functional
tropohblast and thereby verifies the existence ofa pre-
sumedpregnancy (77). Adecline intherisinghCGtiters
signals the interruption ofpregnancy but does not iden-
tify the cause or the site of interruption. All this is
certified by an extensive literature. This has made way
forageneralapprovalofthismethod, soitnowhasbeen
proposed to extend hCG-RIA to monitor the sequelae
of environmental exposure of populations that include
reproductively competent women (National Research
Council Committee on Biomarkers in Reproductive and
Developmental Toxicology).
Human Trophoblast Differentiation and
hCG Synthesis
Syncytialization (fusion ofcytotrophoblast cells) char-
acterizes the development ofthe definitive human hem-
ochorialplacenta(78). Insituhybridization haslocalized
the a subunit mRNA to cytotrophoblast, syncytiotro-
phoblast, and theintermediate formsthatrepresentthe
transition between the two definitive cell types (Table
2). However, the P subunit mRNA canbe localized only
to the intermediate form and syncytiotrophoblast (79).
This confirms the immunocytochemical data that local-
izes the intact hCG molecule in the syncytiotrophoblast
but not the cytotrophoblast (80,81). This strongly sug-
gests that trophoblast differentiation must be in prog-
ress before the 1B subunit becomes available for dimer-
ization with the a subunit and the rapid secretion ofthe
intact hCG molecule. It is notable thatincrease in DNA
content per trophoblast cell (regardless of the mecha-
nism by which this is accomplished) is a correlate of
both hCG secretion by syncytiotrophoblast and PL se-
cretionby rat giant cells (Table 2). Since both synthesis
and secretion of mature placental peptide hormone
(hCG, PL) and the increase in DNA/cell occur during
differentiation of trophoblast cells, it is reasonable to
inquire as to the nature and importance of these rela-
tionships. Ifalterations in DNA are integral to the ac-
tions of a xenobiotic agent (69), changes such as those
occurringintrophoblast cells could dictate limits ofsen-
sitivity and response.
Recombinant DNA technology has been used, to an
extent, to studythe regulation ofplacental peptide hor-
mones. However, recombinant DNAtechnologyhasnot
rigorously addressed the questions of gene expression
relative to the nature of genome replication or the re-
lationship, ifany, betweenthefirsthormone(hCG, rPL-
1) and second hormones (hPL, rPL-2) expressed by the
differentiating trophoblast cell.
An In Vitro Model to Study Human
Trophoblast Differentiation
There is an experimental model that can be adapted
to study the differentiation of the human trophoblast
cell. Any variety of methods, including recombinant
DNA technology, can be used to analyze the transition
from cytotrophoblast to syncytiotrophoblast. The sys-
tem would also be excellent for investigating the con-
sequences ofintroducingxenobioticagentsanddifferent
steps in trophoblast differentiation. Friedman and Ske-
han(42)describedadirectoryofmorphologicalandfunc-
tional properties that characterized the transition of
cytotrophoblastlike (CTL) cells ofthe BeWo choriocar-
cinoma cell line to syncytiotrophoblastlike (STL) cells.
Cytologically, CTL and STL were identical to their
counterparts in utero.
BeWo CTL cells constitute 96to 99% ofthe celltypes
ofthe stored cellline (Table3). Cultured inthepresence
of subthreshold levels of methotrexate, the CTL cells
will differentiate. At the end of a 96-hr culture period,
over90% ofthe cells express STLmorphology andfunc-
tion. When methotrexate is removed, the STL cells
shuttle backwards to become CTL. It should be noted
that although the presence ofmethotrexate suppressed
DNA synthesis, there is still a 66% increase in DNA/
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Table 2. Relationship between expression of early placental peptide hormone (hCG, rPL) and DNA/cell during differentiation of
human and rat trophoblast.
Cytotrophoblast Intermediate Syncytiotrophoblast
Human a-hCG mRNA + + +
,B-hCG mRNA + +
a-hCG synthesis + + +
,B-hCG synthesis + +
Intact hCG - + +
DNA (pg/cell) 20 33
Rat ectoplacental EPC EPC giant cell derivatives
cone cells
DNAc 2 2/4 4 4/8 8 8/16 16
rPL - - - - + +/++ +++
Table 3. Characteristics of an in vitro experimental model
expressed during differentiation ofBeWO choriocarcinoma cell-
line cytotrophoblastlike (CTL) to syncytiotrophoblastlike (STL)
cells.'
(+)
1 ,uM Methotrexate
CTLb STLb
96-99% (-) 90+%
Proliferative Nondividing
Mononucleate Multinucleate
Moderate size Giant (increase 3-10)
Mononucleate Multinucleate
Cytoplasmic (4)
filaments
Ruffles (Transitional or (4)
Desmosomes intermediate types (4)
Fascia adherens were not studied) (4)
junction
Microvilli (t)
Golgi U)
Vesicles ()
Granules ()
Smooth endoplasmic (t)
reticulum, dilated
DNA: 20 pg/cell 33 pg/cell (+66%)C
Protein: 169 pg/cell 1163 pg/cell (+700%)
hCG (+) (+ + +)
'Friedman and Skehan (42).
bCTL and STL similar to in utero cytotrophoblast and syncytio-
trophoblast.
C40% STL appear to be endoreduplicative.
cell coincident with the expression of increased levels
ofhCG.
Essentially no work has been done with this ex-
tremely promising model, either in terms of cell inva-
siveness or the synthesis of hCG. Nor has there been
any analysis of the intermediate forms in either direc-
tion. A significant data base drawing on studies of the
molecular biology of gene regulation of hCG (82), the
endocrine physiology ofresponse to cAMP, the molec-
ular basis for second messenger response (83), and the
cell biology ofcytoskeletal changes (42,66) could be ap-
plied to this experimental system, which would add a
dimension that could expand the utility of hCG as
marker ofrisk exposure in early pregnancy.
The effectiveness ofhCG as marker forearlypostim-
plantation development would be enhanced if the reg-
ulatory relationships between the undifferentiated (cy-
totrophoblast) and differentiated (syncytiotrophoblast)
trophoblast cells and their intermediates could be re-
solved. Since the sensitivity and the response of each
cell variant to normal regulatory and xenobiotic agents
may prove to be different, understanding the contri-
bution ofeach to the form and function ofthe definitive
placenta is critical to the assessment of environmental
risk.
Limits of hCG as a Marker
The utility of hCG as either a biological or health
marker is limited by the onset ofits appearance at sites
accessible to sampling. Human chorionic gonadotropin
can first be reliably detected 10 days afterthe midcycle
LH surge (84), 3 to 4 days after the blastocyst has
implanted on the uterine endometrium (Fig. 15). Given
this chronology, it is possible that intact hCG (and its
subunits) could be expressed prior to day 10. Because
ofitsubiquity, measurementoftheasubunit(expressed
by cytotrophoblasts before they initiate differentiation)
would be equivocal. The earliest measurement of the
intact hormone would depend on the differentiation of
sufficient numbers of intermediate and terminal syn-
cytiotrophoblast cells to produce sufficient hCG to be
detected by the sensitivity of the assay.
Therefore, there is no effective biological marker, in-
cluding hCG, to monitor events associated with tran-
sition from morula to blastocyst, entry into the uterus,
and the various pre- and peri-implantation events that
occur during days 5 to 10 (Fig. 15). The report (85) that
a luteotropic hCG-like factor is produced by the human
blastocyst and is detectable in the immediate preim-
plantation period (day6) has neverbeen confirmed. Ag-
gressive prospective research, largelydependent onan-
imal and/orexperimentalmodels, isrequired toidentify
trophoblast signals thatmight be expressed duringthis
critical, high-risk period (days 5-7, 5-10).
At present, the most promising marker to character-
ize this developmental period is an endometrial signal,
the luteotropiclike peptide product of the predecidual
cells ofthe late secretory uterine stroma (86). Decidual
cell signals have also been identified in the rat (87).
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FIGURE 15. This diagram depicts some of the major events occurring in utero that define the pen-implantation period in the human. Note
the absence ofconfirmed markers available during that period. Sensitive radioimmunoassays ofhCG, using specific monoclonal antibodies,
do not detect hCG until day 10, at least 3 days after implantation and initiation oftrophoblast differentiation. Early pregnancy factor (EPF)
and pregnancy-associated factor (PAF) are trophoblast (?) products that could be used as markers of the risk status of the embryo. The
decidual luteotropic hormone could possibly serve as a marker ofthe condition of the endometrium.
There are no trophoblast signals characteristic of this
period, although EPF (earlypregnancyfactor)and PAF
(pregnancy-associated factor) have been touted as can-
didates to mark this sensitive period of development
(Fig. 15). The value of EPF and PAF would be aug-
mented ifthe sites oftheir production could be certified
and if their expression could be demonstrated to be a
correlate of, rather than coincident with, a pivotal step
in development. The potential importance ofthese pos-
sible markers deserves stringent study and support.
Future Studies
The research plan designed to identify trophoblast
signals that might be used to monitor the influence of
xenobiotic agents on early gestation is depicted in Fig-
ure 16. Theabilitytodistinguishbetweenaliveanddead
embryos might satisfy first efforts; however, lethality
is a rudimentary marker with relatively little infor-
mation value. Peri-implantation death carries a mini-
mumburden, as such lossescould occurwithoutaltering
the scheduling of the normal menstrual (reproductive)
cycle. Therealityisthatchronicrecurrence ofthisevent
could be misinterpreted as some form of infertility
rather than a more direct penalty of toxic exposure.
Finally, however, markers arerequired to approximate
injury, repair, and the nature ofdegree ofaltered func-
tion in those conceptuses that do not die immediately
and in those that survive. The survival of individuals
injured in utero exacts onerous psychological and so-
cioeconomic burdens.
Theresearchplanwasdesignedforanalysisofinvitro
experimental models and is based on the episodic ex-
posure of a target cell to any particular agent. Chronic
exposures may represent more of a real-life situation.
However, an experimental model is better served by
episodic exposures that permit the pharmacodynamics
and the sensitivity ofa single target-cell to be analyzed
at any single stage ofits differentiation. It is then pos-
sible to monitor the sequelae ofan episodic exposure at
that stage ofceli development.
In terms ofgenerating trophoblast signals, injury to
the undifferentiated trophoblast (human cytotropho-
blast, rodent trophectoderm) is expected to produce
more serious deficits and far-reaching effects on the
products of conception than injury at later develop-
mental stages. Theundifferentiated trophoblastcellcan
be regarded as a determined stem celi (Fig. 16) that
becomesincreasinglycommittedtothetrophectodermal
epithelial lineage as it develops from compaction to the
earlyblastocyst. The consequences ofinjury are factors
ofthe sensitivity ofthe target cell and pharmacokinetic
principles. The greater the number oftarget cells that
can differentiate, i.e., human intermediate and synctio-
trophoblast, rodent trophoblast giant cells, the fewer
the earlier in utero deaths.
There are no studies on the transitional forms ofdif-
ferentiating human trophoblast, but studies of rat or
mouse offer opportunities to investigate the relation-
ships between differentiation and sensitivity. In the ro-
dent there are three variants of the undifferentiated
trophoblast cell in the blastocyst. Because of their lo-
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FIGURE 16. A scheme used to track the possible sequelae of exposure of a target cell to effective concentrations of a xenobiotic agent. In
comparison with in utero cell death, the greatest burden and the most far-reaching individual and population effects are related to the
nonrepairable injury of undifferentiated (stem) trophoblast cells, i.e., human cytotrophoblast; rodent trophectoderm. Also at considerable
risk are the differentiated derivatives ofthe stem cell pool (daughter cells), i.e., human syncytiotrophoblast; rodent trophoblast giant cells.
The putative sensitivity ofthese cells may be related to the increase in DNA per cell that characterizes their differentiation and the pivotal
role these cells play in development because of their morphological and functional contributions to the definitive placenta. See text for
further discussion.
cation and proliferative rates, mural TE, polar TE and
EPC cells mayhavedifferingsensitivities to aparticular
xenobiotic agent. Thus, if the blastocyst is exposed in
the interval immediately preceding attachment to the
uterine epithelium, the initial stages oftrophoblast dif-
ferentiation and thereby the synthesis and secretion of
the early trophoblast peptide hormone (human hCG,
rodent PL-1) would be seriously affected, primarily be-
cause of interference with mural TE. If exposure was
severeenough (concentration, duration) that asufficient
number ofTGC did not develop, then pregnancy would
terminate at the immediate postimplantation period.
However, TGC from polar TE and EPC differentiate
at later developmental periods, so that ifthe threshold
requirement subsequent to attachment at the abem-
bryonal/antimesometrial site were satisfied, sufficient
recovery in the precursor pool ofsecondary TGC could
takeplace. Depending onthe extentofinterferencewith
the expression ofother regulating signals (hPL, rodent
PL-2, signals for gastrulation, specific organogenetic
switches), consequences would be most probably noted
as fetal and neonatal death.
The spectrum ofeffects is shifted ifcritical exposure
occurs after differentiation has been initiated (e.g., at
the daughter cells stage) (Fig. 16). Again, there is no
literature regarding derivatives ofundifferentiated cy-
totrophoblast or TE cells. In the human the effect of
critical exposure of syncytiotrophoblast cells would be
the result ofmultiple factors. If a sufficient number of
these cells survived functionally to maintain the preg-
nancy, the consequences would derive from the com-
petence to initiate other endocrine functions (hPL,
steroidogenesis), the ability to serve the cell-cell inter-
actions required for villous formation, etc. Changes
would be modulated by the capacity ofthe proliferating
pool of recovering trophoblast cells to affect homotypic
repair and could carry development well into the fetal
period. Term pregnancies ofdead fetuses (88), neonatal
Cell Death
I
Termination
Of Pregnancy
ions
(Term Pregnancy)
Constitutionally Impaired
Survivors (Possible Trans-
generatinal Burden) i
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deaths, and the birth ofimpaired survivors are lasting
penalties of postimplantation exposure.
In the rodent, the responses ofpresumptive placenta
to a xenobiotic agent critically localized in the differ-
entiating trophoblast cell might be expected to be more
variable. Once differentiation has been initiated, the
TGC are postmitotic, and as development proceeds, in-
creasingly terminally differentiated. Without prospec-
tive research it is not possible to predict how a DNA
adduct would be processed by an endoreduplicating nu-
ceus or whether repair, if it does occur, is homotypic
or heterotypic. The contribution from the EPC reser-
voirofdiploid proliferative cellswouldbeanotherfactor
for which no estimates exist. Not only are these cells a
continuing source of TGC (PL-2), but formation ofthe
definitive trilaminar trophoblast (65) depends on their
responses to inductive signals emanating from advanc-
ing fetal mesenchyme. The net effect of early postim-
plantation exposure in the rodent is similar to the hu-
man, e.g., fetaldeaths, neonataldeath, andanincreased
incidence ofburdened survivors.
Integratedwiththeuseofacceptable biologicalmark-
ers, which can be used experimentally, a series of ep-
isodic exposures ofrodent trophoblast cells at different
stagesofdifferentiation cangenerate apatternofstage-
specific responses. In the idiom of these experiments
the risk ofeach developmental stage can be more spe-
cifically assessed. These relative values could be ex-
trapolated to early human trophoblast differentiation.
It is possible that such extrapolative exercises could
providegreaterclarityand directiontoestimates ofrisk
in human population. At the minimum, they indicate
how dissatisfied we should be with our present knowl-
edge and provide direction for future efforts.
NOTE ADDED IN PROOF: Kliman, H. J., Nestler, J. E.,
Sermasi, E., Sanger, J. M., and Strauss, J. F. III [En-
docrinology 118: 1567-1582 (1986)] have recently re-
ported onthepurification, characterization, and invitro
differentiation of cytotrophoblasts from human term
placentae. This cell separation has the same potential
as the Friedman and Skehan model (42), which uses
BeWo choriocarcinoma cells plusthe advantage ofusing
primary, albeit term, cells. Neither model, both of
which support the same concept relating DNA/cell to
the expression of mature hCG, has been confirmed or
challenged experimentally.
These studies were supported by funds from HD-07495 and March
of Dimes Basic Research Grant 1-905. MJS was supported by an
NRSA Postdoctoral Fellowship HD-06363.
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